School of Medicine
Showing 1-50 of 237 Results
-
Vyas Akondi
Senior Research Scientist - Basic Life, Ophthalmology
Current Role at Stanford My role is to advance the development of next-generation clinically relevant adaptive optics ocular imaging devices to allow early disease diagnosis and monitoring through a non-invasive visualization of subcellular structures in the eye.
-
Deborah Alcorn, MD
Associate Professor of Ophthalmology at the Stanford University Medical Center, Emerita
Current Research and Scholarly Interests Gene linkage - tuberous sclerosis; stabismus and, molteno implants; congenital stationary night blindness
-
Jill Beyer, OD
Clinical Assistant Professor, Ophthalmology
Bio Jill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill?s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly Interests Clinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations. -
Robert Chang, MD
Associate Professor of Ophthalmology at the Stanford University Medical Center
Current Research and Scholarly Interests I'm interested in digital health, commercialization of new technology, and the biodesign education process. I have expertise in mobile health and clinical validation of new eye care devices.
-
Fang Chen (Rosy)
Postdoctoral Research Fellow, Ophthalmology
Current Research and Scholarly Interests Corneal regeneration via hydrogel-based cell scaffold and cell encapsulation
-
Wei Chen
Postdoctoral Research Fellow, Ophthalmology
Bio My long-term goals involve the development of a full understanding of key molecular mechanisms and the identification of corresponding therapeutics for human diseases. My research training and academic experience have provided me with an excellent background necessary in multiple fields including molecular biology, cell biology, medicinal chemistry, and biochemical pharmacology. As an undergraduate, I have learned numerous biology and physiology courses, which let me appreciate and understand biological diversity. As a predoctoral student, my research focused on the identification and evaluation of fusion proteins, gene therapy-based biologics, molecular modifiers and inhibitors to treat tissue injury or cancer. We first revealed a novel mechanism underscoring the regulation of metabolic profiles and mitochondrial function of epithelial cells by IL-22 during cell injury, which might provide useful insights from the bench to the clinic in treating and preventing more diseases, especially acute stroke/traumatic brain injuries. We subsequently demonstrated that autophagy was induced to play cytoprotective roles in numerous cells, which highlighted the potential therapeutic strategies for CNS neurodegeneration diseases or cancer by targeting autophagy. During my undergraduate and graduate careers, I also received several academic awards, including two times National Scholarship. For my postdoctoral training, I will continue to build on my previous researches in metabolic profiles and mitochondrial function regulations by concentrating on determining the role of mitochondrial thioredoxin metabolism in neuronal survival. These new scientific issues will allow me to address additional problems regarding the molecular basis of neurodegeneration and develop a neuroprotective gene therapy strategy to protect CNS neurodegenerative diseases/injuries.
-
E.J. Chichilnisky
John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering
Current Research and Scholarly Interests Functional circuitry of the retina and design of retinal prostheses
-
Diana Do, MD
Professor of Ophthalmology at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Do's research focuses on collaborative clinical trials to investigate novel treatments for retinal vascular diseases and ocular inflammation. She performs research to develop state of the art therapies for age-related macular degeneration, diabetic eye disease, retinal vein occlusion, retinal inflammation, and retinal detachment.
-
Alfredo Dubra, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly Interests Our lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.
-
Peter R. Egbert, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly Interests Ocular pathology of shaken baby syndrome